Rodman & Renshaw Initiates NuVasive at Market Perform (NUVA)

By Chip Brian, SmarTrend Analytics Team

01/08/2010-NuVasive (NASDAQ:NUVA) was initiated at Rodman & Renshaw Friday with a Market Perform.

The firm says NuVasive’s position as the #5 player in spine surgery sector mandates its rating.

Furthermore, the firm says the spine surgery sector currently is valued at $8 billion and has favorable growth drivers such as the aging population and rising obesity behind it.

However, the firm remains cautious due to its belief that a market-wide shock could have a multiplier effect on NuVasive given its lack of diversification.

Contact Chip Brian


Josh Sandberg

Josh Sandberg is the President of Ortho Spine Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button